Could a dye and camera spare esophageal cancer patients from extensive lymph node removal?

NCT ID NCT04400292

First seen Jul 07, 2026 · Last updated Jul 08, 2026 · Updated 1 time

Summary

This study explores whether a dye called indocyanine green (ICG) and a special camera can help surgeons find the first lymph nodes that esophageal cancer may spread to. If this 'sentinel lymph node' mapping works, future surgeries might remove only those key nodes instead of all nearby lymph nodes. The trial involves 90 adults with distal esophageal or esophagogastric junction cancer who are already scheduled for minimally invasive esophagectomy.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Indocyanine green (ICG) dye
What this could lead to
If successful, this approach could allow surgeons to remove only key lymph nodes instead of all of them, reducing surgical side effects.
What could go wrong
This is an early-stage study with only 90 participants, and the technique may not reliably identify all affected nodes, limiting its use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ESOPHAGEAL ADENOCARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Memorial Sloan Kettering Cancer Center (All Protocol Activities)

    New York, New York, 10065, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.